Company profile
AB2 Bio SA
AB2 Bio SA is a Swiss biopharmaceutical company developing “best in class” innovative therapies for the treatment of inflammatory diseases with large unmet medical needs and major market opportunities.
Source: startup.ch
More news about AB2 Bio SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
